Status:
COMPLETED
Endomicroscopy for Assessment of Mucosal Healing
Lead Sponsor:
University of Erlangen-Nürnberg Medical School
Conditions:
Crohn´s Disease
Ulcerative Colitis
Eligibility:
All Genders
18-85 years
Brief Summary
Inflammatory bowel disease (IBD) encompasses two major forms of chronic intestinal disorders, Crohn's disease and ulcerative colitis (UC). Diagnosis is based on several macroscopic and histologic feat...
Eligibility Criteria
Inclusion
- Written informed consent
- Age 18-85 years
- Ability of subjects to understand character and individual consequences of clinical trial
- Subjects undergoing colonoscopy
Exclusion
- Inability to provide written informed consent
- Severe Coagulopathy (Prothrombin time \< 50% of control, Partial thromboplastin time \> 50 s)
- Pregnancy or breast feeding
- Active gastrointestinal bleeding
- Residing in institutions (e.g. prison)
- Known allergy against fluorescein
- Proctocolectomy
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2014
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT01417715
Start Date
August 1 2011
End Date
August 1 2014
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Erlangen-Nuremberg
Erlangen, Germany, 91054